Celldex Therapeutics, Inc. (CLDX) Covered Calls

Celldex Therapeutics, Inc. covered calls Celldex Therapeutics, Inc is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease.

You can sell covered calls on Celldex Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CLDX (prices last updated Fri 4:16 PM ET):

Celldex Therapeutics, Inc. (CLDX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
23.55 -2.19 23.15 25.54 1.2M - 1.7
Covered Calls For Celldex Therapeutics, Inc. (CLDX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 22.5 1.95 23.59 -4.6% -46.6%
Jan 17 23 2.80 22.74 1.1% 6.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Celldex Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. Its lead drug candidates include rindopepimut, glembatumumab vedotin and varlilumab. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.